Laidi, C. et al. Factors associated with direct health care costs in schizophrenia: results from the FACE-SZ French dataset. Eur. Neuropsychopharmacol. 28, 24–36 (2018).
Google Scholar
Charlson, F. J. et al. Global epidemiology and burden of Schizophrenia: findings from the global burden of disease study 2016. Schizophr. Bull. 44, 1195–1203 (2018).
Google Scholar
Na, K.-S., Jung, H.-Y. & Kim, Y.-K. The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 48, 277–286 (2014).
Google Scholar
Hilker, R. et al. Heritability of Schizophrenia and Schizophrenia spectrum based on the nationwide danish twin register. Biol. Psychiatry 83, 492–498 (2018).
Google Scholar
Tsuang, M. Schizophrenia: genes and environment. Biol. Psychiatry 47, 210–220 (2000).
Google Scholar
Stilo, S. A. & Murray, R. M. Non-genetic factors in Schizophrenia. Cur Psychiatry Rep. 21, 100 (2019).
Google Scholar
Sekar, A. et al. Schizophrenia risk from complex variation of complement component 4. Nature 530, 177–183 (2016).
Google Scholar
Chauhan, P., Kaur, G., Prasad, R. & Singh, H. Pharmacotherapy of schizophrenia: immunological aspects and potential role of immunotherapy. Expert Rev. Neurother. 21, 1441–1453 (2021).
Google Scholar
Escudero-Esparza, A., Kalchishkova, N., Kurbasic, E., Jiang, W. G. & Blom, A. M. The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I-mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly. FASEB J. 27, 5083–5093 (2013).
Google Scholar
Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421-427 (2014).
Ji, E. et al. Peripheral complement is increased in schizophrenia and inversely related to cortical thickness. Brain Behav. Immun. 101, 423–434 (2022).
Google Scholar
O’Connell, K. S. et al. Association between complement component 4A expression, cognitive performance and brain imaging measures in UK Biobank. Psychol. Med. 52, 1–11 (2021).
Google Scholar
Qiu, A. et al. Hippocampal-cortical structural connectivity disruptions in schizophrenia: an integrated perspective from hippocampal shape, cortical thickness, and integrity of white matter bundles. NeuroImage 52, 1181–1189 (2010).
Google Scholar
Yilmaz, M. et al. Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice. Nat. Neurosci. 24, 214–224 (2021).
Google Scholar
Gorelik, A. et al. Developmental activities of the complement pathway in migrating neurons. Nat. Commun. 8, 15096 (2017).
Google Scholar
Gallego, J. A., Blanco, E. A., Morell, C., Lencz, T. & Malhotra, A. K. Complement component C4 levels in the cerebrospinal fluid and plasma of patients with schizophrenia. Neuropsychopharmacology 46, 1140–1144 (2021).
Google Scholar
Donohoe, G. et al. Genetically predicted complement component 4A expression: effects on memory function and middle temporal lobe activation. Psychol. Med. 48, 1608–1615 (2018).
Google Scholar
Hatzimanolis, A. et al. Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability. Eur. Arch. Psychiatry Clin. Neurosci. 272, 1219–1228 (2022).
Google Scholar
Bourel, J. et al. Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis. Neurobiol. Dis. 160, 105533 (2021).
Google Scholar
Holland, J. F. et al. Effects of complement gene-set polygenic risk score on brain volume and cortical measures in patients with psychotic disorders and healthy controls. Am. J. Med. Genet. Part B, Neuropsychiatr. Genet. 183, 445–453 (2020).
Google Scholar
Ji, R. N. et al. Decreased serum complement component 4 levels in patients with schizophrenia. Psychiatr. Genet. 29, 127–129 (2019).
Google Scholar
Su, J., Feng, X., Chen, K., Fang, Z. & Zhang, H. Plasma complement component 4 alterations in patients with schizophrenia before and after antipsychotic treatment. Asian J. Psychiatry 73, 103110 (2022).
Google Scholar
Woo, J. J., Pouget, J. G., Zai, C. C. & Kennedy, J. L. The complement system in schizophrenia: where are we now and what’s next? Mol. Psychiatry 25, 114–130 (2020).
Google Scholar
Mongan, D. et al. Peripheral complement proteins in schizophrenia: a systematic review and meta-analysis of serological studies. Schizophr. Res. 222, 58–72 (2020).
Google Scholar
Rosbjerg, A. et al. Complementary roles of the classical and lectin complement pathways in the defense against aspergillus fumigatus. Front. Immunol. 7, 473 (2016).
Google Scholar
Kouser, L. et al. Properdin and factor h: opposing players on the alternative complement pathway “see-saw”. Front. Immunol. 4, 93 (2013).
Google Scholar
Dalakas, M. C., Alexopoulos, H. & Spaeth, P. J. Complement in neurological disorders and emerging complement-targeted therapeutics. Nat. Rev. Neurol. 16, 601–617 (2020).
Google Scholar
Kopczynska, M. et al. Complement system biomarkers in first episode psychosis. Schizophr. Res. 204, 16–22 (2019).
Google Scholar
Spitzer, R. L., Williams, J. B., Gibbon, M. & First, M. B. The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch. Gen. Psychiatry 49, 624–629 (1992).
Google Scholar
Kay, S. R., Fiszbein, A. & Opler, L. A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13, 261–276 (1987).
Google Scholar
Wechsler, D. WAIS-R Manual: Wechsler Adult Intelligence Scale-revised. (Psychological Corporation, 1981).
Gavett, B. E. et al. Practice effects on story memory and list learning tests in the neuropsychological assessment of older adults. PLoS One 11, e0164492 (2016).
Google Scholar
Yu, H. et al. Association of the plasma complement system with brain volume deficits in bipolar and major depressive disorders. Psychol. Med. 53, 6102–6112 (2023).
Google Scholar
Askari, M. et al. A study of the association between cognitive abilities and dietary intake in young women. Nutr. Health 26, 263–270 (2020).
Google Scholar
Tseng, H. H. et al. Peripheral inflammation is associated with dysfunctional corticostriatal circuitry and executive dysfunction in bipolar disorder patients. Brain Behav. Immun. 91, 695–702 (2021).
Google Scholar
Cai, J., Luo, J., Wang, S. & Yang, S. Feature selection in machine learning: a new perspective. Neurocomputing 300, 70–79 (2018).
Google Scholar
Caldiroli, A. et al. The relationship of IQ and emotional processing with insula volume in schizophrenia. Schizophr. Res. 202, 141–148 (2018).
Google Scholar
Yang, Y. et al. Altered levels of acute phase proteins in the plasma of patients with schizophrenia. Anal. Chem. 78, 3571–3576 (2006).
Google Scholar
Maes, M., Vojdani, A., Sirivichayakul, S., Barbosa, D. S. & Kanchanatawan, B. Inflammatory and oxidative pathways are new drug targets in multiple episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q immune complexes are additional drug targets in first episode Schizophrenia. Mol. Neurobiol. 58, 3319–3334 (2021).
Google Scholar
Hakobyan, S., Boyajyan, A. & Sim, R. B. Classical pathway complement activity in schizophrenia. Neurosci. Lett. 374, 35–37 (2005).
Google Scholar
Zhang, C., Lv, Q., Fan, W., Tang, W. & Yi, Z. Influence of CFH gene on symptom severity of schizophrenia. Neuropsychiatr. Dis. Treat 13, 697–706 (2017).
Google Scholar
Mayilyan, K. R., Arnold, J. N., Presanis, J. S., Soghoyan, A. F. & Sim, R. B. Increased complement classical and mannan-binding lectin pathway activities in schizophrenia. Neurosci. Lett. 404, 336–341 (2006).
Google Scholar
Laskaris, L. et al. Investigation of peripheral complement factors across stages of psychosis. Schizophr. Res. 204, 30–37 (2019).
Google Scholar
Purcell, S. M. et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748–752 (2009).
Google Scholar
Shin Yim, Y. et al. Reversing behavioural abnormalities in mice exposed to maternal inflammation. Nature 549, 482–487 (2017).
Google Scholar
Santos Sória, L., Moura Gubert, C., Ceresér, K. M., Gama, C. S. & Kapczinski, F. Increased serum levels of C3 and C4 in patients with schizophrenia compared to eutymic patients with bipolar disorder and healthy. Revista brasileira de psiquiatria 34, 119–120 (2012).
Google Scholar
Ni, J. et al. A preliminary genetic analysis of complement 3 gene and Schizophrenia. PloS One 10, e0136372 (2015).
Google Scholar
Wang, C. et al. Microglia mediate forgetting via complement-dependent synaptic elimination. Science 367, 688–694 (2020).
Google Scholar
Hammond, J. W. et al. Complement-dependent synapse loss and microgliosis in a mouse model of multiple sclerosis. Brain Behav. Immun. 87, 739–750 (2020).
Google Scholar
Presumey, J., Bialas, A. R. & Carroll, M. C. in Advances in immunology Vol. 135 (ed F. W. Alt) 53-79 (Academic Press, 2017).
Gomez-Arboledas, A., Acharya, M. M. & Tenner, A. J. The role of complement in synaptic pruning and neurodegeneration. ImmunoTargets Ther. 10, 373–386 (2021).
Google Scholar
Carpanini, S. M., Torvell, M. & Morgan, B. P. Therapeutic inhibition of the complement system in diseases of the central nervous system. Front. Immunol. 10, 362–362 (2019).
Google Scholar
Alawieh, A. M., Langley, E. F., Feng, W., Spiotta, A. M. & Tomlinson, S. Complement-dependent synaptic uptake and cognitive decline after stroke and reperfusion therapy. J. Neurosci. 40, 4042–4058 (2020).
Google Scholar
Lizano, P. et al. Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis. Mol. Psychiatry 26, 3430–3443 (2021).
Google Scholar
Ali, F. T. et al. Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: pathophysiological and phenotypic implications. Schizophr. Res. 188, 98–109 (2017).
Google Scholar
Li, H. et al. Plasma levels of Th17-related cytokines and complement C3 correlated with aggressive behavior in patients with schizophrenia. Psychiatry Res. 246, 700–706 (2016).
Google Scholar
Hernandez, L. M. et al. Multi-ancestry phenome-wide association of complement component 4 variation with psychiatric and brain phenotypes in youth. Genome Biol. 24, 42 (2023).
Google Scholar
Prestwood, T. R. et al. Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia. Behav. Brain Res.402, 113101 (2021).
Google Scholar
Stevens, B. et al. The classical complement cascade mediates CNS synapse elimination. Cell 131, 1164–1178 (2007).
Google Scholar
